The store will not work correctly when cookies are disabled.
We use cookies for optimal website function and to better serve our customers. By continuing to browse you agree to the storing of cookies on your device. See our privacy policy for details.
Allow cookies Deny
CAS No.:1190836-34-0; TAS-115. ChemShuttle’s pharma building blocks portfolio includes TAS-115 (CAS No.:1190836-34-0), a dual MET/VEGFR2 inhibitor for cancer therapy. CAS No.:1190836-34-0 serves as a critical pharma building block in developing tyrosine kinase-targeted agents. The company’s pharma building blocks, such as CAS No.:1190836-34-0, undergo rigorous stability testing for preclinical use. Researchers leverage ChemShuttle’s pharma building blocks to optimize TAS-115 (CAS No.:1190836-34-0) for improved pharmacokinetic profiles.